Burrows Scott L
CIK 1853327
Transactions on file
23
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-04 | 2026-09-02 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 18,232 | $1.63M | -0.4% | open → |
| 2026-09-04 | 2026-09-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 200 | $17.8K | -0.1% | open → |
| 2026-09-04 | 2026-09-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 2,016 | $177.5K | +1.1% | open → |
| 2026-09-04 | 2026-09-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 4,384 | $381.9K | +2.1% | open → |
| 2026-09-04 | 2026-09-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 900 | $77.6K | +3.2% | open → |
| 2026-09-04 | 2026-09-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 7,500 | $108.8K | +513.7% | open → |
| 2026-08-06 | 2026-08-03 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 100 | $9.7K | -8.4% | open → |
| 2026-08-06 | 2026-08-03 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 2,300 | $221.5K | -7.6% | open → |
| 2026-08-06 | 2026-08-03 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 5,100 | $485.6K | -6.5% | open → |
| 2026-08-06 | 2026-08-03 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 7,500 | $108.8K | +513.7% | open → |
| 2026-07-05 | 2026-07-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 1,725 | $152.4K | +0.7% | open → |
| 2026-07-05 | 2026-07-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 5,775 | $505.6K | +1.6% | open → |
| 2026-07-05 | 2026-07-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 7,500 | $108.8K | +513.7% | open → |
| 2026-06-27 | 2026-06-25 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 10,000 | $871.4K | +2.1% | open → |
| 2026-06-27 | 2026-06-25 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 5,000 | $435.6K | +2.1% | open → |
| 2026-06-27 | 2026-06-25 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 15,000 | $217.5K | +513.7% | open → |
| 2026-06-04 | 2026-06-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 3,100 | $223.4K | +23.5% | open → |
| 2026-06-04 | 2026-06-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 2,599 | $183.9K | +25.7% | open → |
| 2026-06-04 | 2026-06-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 1,801 | $125.6K | +27.6% | open → |
| 2026-06-04 | 2026-06-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 7,500 | $108.8K | +513.7% | open → |
| 2026-05-02 | 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 12,500 | $892.1K | +24.7% | open → |
| 2026-05-02 | 2026-05-01 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Exer. | 12,500 | $181.3K | +513.7% | open → |
| 2025-09-03 | 2025-09-02 | SYRE Spyre Therapeutics, Inc. | Officer Chief Financial Officer | Sale | 18,428 | $299.6K | +447.2% | open → |
